Enclomiphene vs Oxandrolone
A side-by-side research comparison of Enclomiphene and Oxandrolone across mechanism, dosing, half-life, benefits, side effects and research status.
Comparison table
| Attribute | Enclomiphene | Oxandrolone |
|---|---|---|
| Full name | Enclomiphene Citrate | Oxandrolone (Anavar) |
| Category | Hormone Replacement | Hormone Replacement |
| Status | Investigational drug | FDA Approved (Schedule III) |
| Mechanism | Blocks estrogen receptors in the hypothalamus, reducing negative feedback and increasing GnRH pulsatility, which stimulates LH and FSH release for endogenous testosterone production. | Binds androgen receptors with high anabolic:androgenic ratio (~10:1). Does not aromatize to estrogen. Increases nitrogen retention, protein synthesis, and phosphocreatine resynthesis while reducing SHBG. |
| Molecular weight | 598.09 Da | 306.44 Da |
| Half-life | 10-14 hours | ~9 hours |
| Bioavailability | ~50% oral | ~97% oral |
| Typical dose | 12.5-25 mg | 10-20 mg (therapeutic); 20-50 mg (performance) |
| Frequency | Daily | Split 2x daily |
| Route | Oral capsule | Oral |
Enclomiphene reported benefits
- Increased endogenous testosterone
- Preserved fertility
- Improved libido
- Enhanced energy and mood
- No testicular atrophy
Oxandrolone reported benefits
- Lean muscle gain without water retention
- Increased strength
- Fat loss (visceral)
- Wound healing acceleration
- Minimal estrogenic effects
- Improved bone density
Related comparisons
Research and educational reference only. Not medical advice.